Landmark study involving babies in Ireland supports use of Cystic Fibrosis drug in infants from four weeks of age

A Cystic Fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective in newborns aged four weeks and ab....

Related Keywords

United Kingdom ,Ireland ,United States ,Paul Mcnally ,Isaac Moss ,Ivacaftor Kalydeko ,University Of Medicine ,Children Health Ireland ,European Medicines Agency ,Vertex Pharmaceuticals ,Health Sciences ,Cystic Fibrosis ,Health Ireland ,Associate Professor ,Respiratory Medicine ,